Other
Hysterectomy
100
Pipeline Programs↗
28
Active Trials↗
44
Companies Involved↗
Hysterectomy is a moderately active landscape with 100 programs across 44 companies. The most active players are Milestone Pharmaceuticals Inc., Amring, Cara Therapeutics, Inc.. 54 therapies are approved with 13 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical20
Phase 11
Phase 212
Phase 313
Analysis
Trial Status
135
clinical trials
Completed78 · 58%
Unknown status21 · 16%
Recruiting18 · 13%
Not yet recruiting7 · 5%
Terminated4 · 3%
Withdrawn4 · 3%
Other3 · 2%
Clinical Trials
Trial Activity
135 trials
Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy
Recruiting·—·N/A·NCT07435909·120 enrolled
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Recruiting·—·N/A·NCT06493968·70 enrolled
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
Recruiting·—·Phase 2·NCT06483659·152 enrolled
Intrathecal Morphine Versus Trocar-Site and Intraperitoneal Bupivacaine for Quality of Recovery After Laparoscopic Hysterectomy
Recruiting·—·N/A·NCT07232108·64 enrolled
Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy
Recruiting·—·N/A·NCT06837506·80 enrolled
Clinical Study of Equivalent Doses of Oxycodone or Tegileridine on Patients Undergoing Gynecological Laparoscopic Hysterectomy
Recruiting·—·Phase 4·NCT07326683·92 enrolled
Page 1 of 9
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)